ライフサイエンスコーパス: oral swab

1 eloped a saliva collection workflow using an oral swab.

2 reports of M. tuberculosis DNA detection in oral swabs.

3 f. sp. carinii DNA was amplified from 98% of oral swabs.

4 participants (19.2%) for obtaining nasal or oral swabs, 159 participants (15.9%) for placing an intr

5 participants (30.7%) for obtaining nasal or oral swabs, 228 participants (22.8%) for placing an intr

6 terium tuberculosis DNA can be detected from oral swabs, a noninvasive, safe alternative sample type;

7 tudy evaluated the biological feasibility of oral swab analysis (OSA) for the diagnosis of TB.

8 Although oral swab analysis had low sensitivity in sputum-positiv

9 Real-world forensic analyses of oral swab and human bone extracts from case evidence wer

10 both of the commercially available methods (oral swab and/or spit tubes), CandyCollect devices had a

11 Oral swabs and induced sputum (IS) were collected from 2

12 DNA was extracted from oral swabs and lung homogenates, and PCR was performed u

13 vices and traditional commercially available oral swabs and spit tubes.

14 16s rRNA-based analysis was performed on oral swabs and stool samples obtained biweekly from base

15 16s rRNA based analysis was performed on oral swabs and stool samples obtained biweekly from base

16 with RAVV and quantify viral loads in blood, oral swabs, and rectal swabs over a 21-day timeline with

17 Oral swabs are a promising non-sputum alternative sample

18 act or derive sensitivity and specificity of oral swabs as a sample type for the diagnosis of pulmona

19 s needed to define optimal methods for using oral swabs as a specimen for tuberculosis detection.

20 iagnosis from standard nasopharyngeal and/or oral swabs (both on extracted and non-extracted RNA samp

21 acterial composition was analyzed from whole oral swabs collected from 12- to 14-week-old TLR2, TLR4,

22 ast 6 months and blood samples and nasal and oral swabs collected, alongside physical examination dat

23 evelopment of appropriate automated methods, oral swabs could facilitate TB diagnosis in clinical set

24 Armored RNA spiked into oral swab fluid specimens mimicked virus-positive clinic

25 e armored RNA concentrations spiked into the oral swab fluid specimens were stable under storage cond

26 in or placebo delivered enterally and via an oral swab for up to 28 days.

27 at reported diagnostic accuracy estimates on oral swabs for pulmonary tuberculosis.

28 to evaluate the use of PCR amplification of oral swabs for the antemortem detection of Pneumocystis

29 ndividuals who were live suspected cases and oral swabs from individuals who were deceased to diagnos

30 We collected weekly oral swabs from young children and mothers in 32 Ugandan

31 Oral swabs have been proposed as alternative sample type

32 With further development, oral swabs may become useful supplements to sputum as sa

33 did not reveal the presence of viral RNA in oral swabs of bats in the absence of brain infection.

34 Forty-four (40.4%) had HSV-2 detected from oral swabs on at least 1 day.

35 ted a range of coronaviruses in fecal swabs, oral swabs or stool specimens from seven species.

36 Thus, oral swab/PCR is a rapid, nonlethal, and sensitive metho

37 e, peak viremia, viral shedding in nasal and oral swabs, peak cytokine levels, and time to reach endp

38 ther Confirmed or Unconfirmed TB, PCR on two oral swabs per child was 31% sensitive and 93% specific,

39 Relative to Confirmed TB, PCR on two oral swabs per child was 43% sensitive and 93% specific.

40 g telehealth interviews, obtaining nasal and oral swabs, placing an intravenous catheter, and perform

41 s, acquiring vital signs, obtaining nasal or oral swabs, placing an intravenous catheter, performing

42 Sensitivity on oral swabs ranged from 36% (95% CI 26-48) to 91% (80-98)

43 anscriptomic libraries from individual mouse oral swabs, representing health and disease.

44 tive healthy adults collected anogenital and oral swabs, respectively, 4 times per day for 60 days.

45 accessible non-sputum specimens (eg, urine, oral swabs, saliva, capillary blood, and breath) are bei

46 g (laryngeal swabs, nasopharyngeal aspirate, oral swabs, saliva, mouth wash, nasal swabs, plaque samp

47 Oral swab samples are non-invasive, non-viscous, and eas

48 We investigated whether easily-obtained oral swab samples are useful alternatives or supplements

49 al communities present in blood, faeces, and oral swab samples collected from two genera of bats (Car

50 comparative study of 428 plasma, urine, and oral swab samples from 334 individuals from TB endemic a

51 DNA in vaginal, anal, and oral swab samples from enrollment was subjected to quant

52 We collected and analysed 355 oral swab samples from stray dogs in Rajshahi and Chatto

53 Oral swab samples were collected daily during the study,

54 No positive nasal or oral swab samples were identified on RT-PCR.

55 can detect SPPV in buffy coats, nasal swabs, oral swabs, scabs, and skin lesions as well as in lung a

56 Oral swabs sensitivity was 56.7% (44.3-68.2), specificit

57 The overall yield was 6.9% with 1 oral swab specimen and 7.2% with 2.

58 A single oral swab specimen was obtained from 126 (43%) of the pa

59 s a prospective diagnostic accuracy study of oral swab specimens (buccal and tongue) for pulmonary tu

60 Oral swab specimens are a potential noninvasive alternat

61 ecimens from live patients and 21 (20%) from oral swab specimens from deceased patients.

62 Use of the Xpert MTB/RIF Ultra assay with oral swab specimens provides poor yield for microbiologi

63 Oral swab specimens were obtained before sputum specimen

64 cal blood and plasma samples and post mortem oral swabs submitted to the Liberian Institute for Biome

65 in the salivary glands and tongue and in an oral swab, suggesting that LBV is transmitted in the sal

66 ure and Xpert Ultra), combined urine LAM and oral swab testing (either sample positive) was significa

67 a 4-week period, participants provided daily oral swabs that we analysed for the presence and quantit

68 e aimed to assess the diagnostic accuracy of oral swabs to detect pulmonary tuberculosis in adults an

69 We subsequently collected ocular swabs, oral swabs, urine samples, and blood samples from patien

70 Oral swabs were collected from M. bovis-unexposed buffal

71 Nasal and oral swabs were collected from patients seen in the outp

72 Oral swabs were collected in the presence and absence of

73 Ocular and oral swabs were collected twice daily for 30 days.

74 rolled patients with CAP, nasopharyngeal and oral swabs were taken and tested for eight viral pathoge

75 Oral swabs were tested by PCR targeting IS6110.

76 stive that high accuracy is achievable using oral swabs with molecular testing, more research is need